Finance Home - My Yahoo - Yahoo! - Help

Wednesday, November 25, 2009, 11:51PM ET - U.S. Markets Closed. Dow  0.29% Nasdaq  0.32%

Pharmaceutical Product Development Inc. (PPDI)

At 4:00PM ET: 21.75   0.14 (0.65%)

MORE ON PPDI

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Competitors Get Competitors for:
DIRECT COMPETITOR COMPARISON   PPDI CVD PRXL Pvt1 Industry Market Cap: 2.57B 3.45B 744.91M N/A 81.78M Employ­ees: 10,000 8,826 9,275 21,0001 394 Qtrly Rev Growth (yoy): -13.50% 5.60% -3.80% N/A 13.50% Revenue (ttm): 1.44B 1.92B 1.23B 2.70B1 141.20M Gross Margin (ttm): 48.92% 30.66% 30.52% N/A 47.15% EBITDA (ttm): 307.64M 324.37M 127.16M N/A 8.84M Oper Margins (ttm): 16.95% 12.45% 5.84% N/A 6.81% Net Income (ttm): 169.52M 180.02M 38.13M N/A N/A EPS (ttm): 1.580 2.808 0.659 N/A N/A P/E (ttm): 13.77 19.19 19.44 N/A 23.64 PEG (5 yr expected): 2.08 1.49 1.02 N/A 1.38 P/S (ttm): 1.77 1.80 0.61 N/A 1.80 CVD = Covance Inc. PRXL = Parexel International Corp. Pvt1 = Quintiles Transnational Corp. (privately held) Industry = Medical Laboratories & Research 1 = As of 2007   NEWS ON DIRECT COMPETITORS   • CVD We Expect Ailing CROs to Recover Wed 7:00am - Morningstar.com • CVD China Biotech Week in Review: CROs Consolidating Sun, Nov 22 - at Seeking Alpha • CVD The Stockpickers: Fund managers hunt small-caps that can grow bigger Fri, Nov 20 - at MarketWatch • CVD Zacks #5 Rank Additions for Friday Fri, Nov 20 - Zacks.com • CVD Rules-Based Medicine Forms Biomarker Alliance With Covance Inc. Wed, Nov 18 - PR Newswire • CVD Covance Enters Into a Biomarker Alliance With Rules-Based Medicine, Inc. Wed, Nov 18 - PR Newswire • PRXL PAREXEL Experts to Discuss Impact of Pharmacovigilance Trends on Biosimilars and Generics at World Generic Medicines Congress Americas Wed, Nov 18 - PR Newswire • PRXL Perceptive Informatics Expands Nuclear Imaging Capabilities for Cardiology Trials Tue, Nov 17 - PR Newswire • PRXL PAREXEL Experts to Discuss Global Capabilities to Meet Urgent Demand For Cardiovascular Treatments at AHA Scientific Sessions Mon, Nov 16 - PR Newswire • CVD How Do You Say 'Drug Development' in Mandarin? Thu, Nov 12 - at Motley Fool • PRXL PAREXEL INTERNATIONAL CORP Files SEC form 8-K, Change in Directors or Principal Officers Thu, Nov 12 - EDGAR Online All Headlines for these symbols... Need more? Get unbiased, in-depth information on public and private companies worldwide from Hoover's Online.
Add to Portfolio     Set Alert     Email to a Friend Get Competitors for Another Symbol: Symbol Lookup • Stock Screener • Sector Analysis